Fig. 8From: Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomesLandscape of the microenvironment phenotypes in NSCLC. (A) Heatmap representation of TME subtype Fges from TCGA NSCLC cohort using unsupervised hierarchical clustering. Distribution of Nrf2-activating MU and Nrf2-inactivating MU according to four TME subtypes (B) and five immune subtypes (C) in TCGA NSCLC cohort. (D) Immune deconvolution using xCell enriched in Nrf2-activating MU and Nrf2-inactivating MU patients with NSCLC. (E) Violin plots of TCR Richness among Nrf2-activating mutations, Nrf2-inactivating mutations, unknown NFE2L2 mutations and WT groupsBack to article page